Table 1 Overview of study population of each included study
Study | ORIF | IMN | DFR | ORIF ROM° | IMN ROM° | DFR ROM° | ORIF KSS | IMN KSS | DFR KSS | ORIF WOMAC | IMN WOMAC | DFR WOMAC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agarwal [19] | 11 | – | – | 98.5 | – | – | 85 | – | – | – | – | – |
Bezwada [20] | 12 | 18 | – | 90.0 | 95.0 | – | 82 | 84 | – | – | – | – |
Gavaskar [21] | 20 | – | – | 106.0 | – | – | – | – | – | 75.8 | – | – |
Gliatis [22] | – | 10 | – | – | – | – | – | – | – | – | 58.5 | – |
Gondalia [23] | 24 | 18 | – | 96.5 | 105.7 | – | 77.2 | 81.8 | – | – | – | – |
Kilicoglu [24] | 9 | 7 | – | 82 | 82 | – | 78.8 | 72.7 | – | – | – | – |
Kolb [25] | 23 | – | – | 102 | – | – | 78 | – | – | 30.2 | – | – |
Bae [26] | 33 | – | – | 98.9 | – | – | 84.6 | – | – | – | – | – |
Lee [27] | – | 25 | – | – | 111 | – | – | 81.5 | – | – | 30.2 | – |
Park [28] | 21 | 20 | – | 104 | 100 | – | – | – | – | 24.4 | 27.4 | – |
Kim [29] | 32 | – | – | 103.6 | – | – | 85.8 | – | – | – | – | – |
Ha, C [30] | 14 | – | – | 107.3 | – | – | 78.9 | – | – | – | – | – |
Darrith [31] | 50 | – | 22 | – | – | – | 86 | – | 84 | – | – | – |